Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 541 AL 555

The Role of Non-coding RNAs in Alzheimer's Disease: Pathogenesis, Novel Biomarkers, and Potential Therapeutic Targets

Saleh O, Albakri K, Altiti A, Abutair I, Shalan S, Mohd OB, Negida A, Mushtaq G, Kamal MA.

CNS Neurol Disord Drug Targets. 2024;23(6):731-745. doi: 10.2174/1871527322666230519113201.

Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial

Brum WS, Docherty KF, Ashton NJ, Zetterberg H, Hansson O, McMurray JJV, Blennow K.

JAMA Neurol. 2024 Feb 1;81(2):197-200. doi: 10.1001/jamaneurol.2023.4719.

Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease

Weinberg MS, He Y, Kivisäkk P, Arnold SE, Das S.

J Alzheimers Dis. 2024;99(s2):S355-S365. doi: 10.3233/JAD-230899.

Navigating the dementia landscape: Biomarkers and emerging therapies

Maheshwari S, Singh A, Ansari VA, Mahmood T, Wasim R, Akhtar J, Verma A.

Ageing Res Rev. 2024 Feb;94:102193. doi: 10.1016/j.arr.2024.102193. Epub 2024 Jan 10.

Monitoring synaptic pathology in Alzheimer's disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives

Lista S, Santos-Lozano A, Emanuele E, Mercuri NB, Gabelle A, López-Ortiz S, Martín-Hernández J, Maisto N, Imbimbo C, Caraci F, Imbimbo BP, Zetterberg H, Nisticò R.

Mol Psychiatry. 2024 Mar;29(3):847-857. doi: 10.1038/s41380-023-02376-6. Epub 2024 Jan 16.

Phase 1/2a Intravenous and Subcutaneous Oligomer-Specific Antibody KHK6640 in Mild to Moderate Alzheimer's Disease

Cantillon M, Andreasen N, Prins N.

J Prev Alzheimers Dis. 2024;11(1):65-70. doi: 10.14283/jpad.2024.2.

Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia

McInvale JJ, Canoll P, Hargus G.

Brain Pathol. 2024 Jul;34(4):e13231. doi: 10.1111/bpa.13231. Epub 2024 Jan 21.

Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis

Chapleau M, La Joie R, Yong K, Agosta F, Allen IE, Apostolova L, Best J, Boon BDC, Crutch S, Filippi M, Fumagalli GG, Galimberti D, Graff-Radford J, Grinberg LT, Irwin DJ, Josephs KA, Mendez MF, Mendez PC, Migliaccio R, Miller ZA, Montembeault M, Murray ME, Nemes S, Pelak V, Perani D, Phillips J, Pijnenburg Y, Rogalski E, Schott JM, Seeley W, Sullivan AC, Spina S, Tanner J, Walker J, Whitwell JL, Wolk DA, Ossenkoppele R, Rabinovici GD; PCA International Work Group.

Lancet Neurol. 2024 Feb;23(2):168-177. doi: 10.1016/S1474-4422(23)00414-3.

A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's disease

van Dyck CH, Mecca AP, O'Dell RS, Bartlett HH, Diepenbrock NG, Huang Y, Hamby ME, Grundman M, Catalano SM, Caggiano AO, Carson RE.

Alzheimers Res Ther. 2024 Jan 25;16(1):20. doi: 10.1186/s13195-024-01382-2.

New horizons in the diagnosis and management of Alzheimer's Disease in older adults

Dolphin H, Dyer AH, Morrison L, Shenkin SD, Welsh T, Kennelly SP.

Age Ageing. 2024 Feb 1;53(2):afae005. doi: 10.1093/ageing/afae005.

Adjunctive silymarin supplementation and its effects on disease severity, oxidative stress, and inflammation in patients with Alzheimer's disease

Navabi SM, Elieh-Ali-Komi D, Afshari D, Goudarzi F, Mohammadi-Noori E, Heydari K, Heydarpour F, Kiani A.

Nutr Neurosci. 2024 Oct;27(10):1077-1087. doi: 10.1080/1028415X.2023.2301163. Epub 2024 Feb 14.

Alzheimer's Disease: A Suitable Case for Treatment with Precision Medicine?

Pauwels EKJ, Boer GJ.

Med Princ Pract. 2024;33(4):301-309. doi: 10.1159/000538251. Epub 2024 Mar 25.

Circulating Biomarkers for Alzheimer's Disease: Unlocking the Diagnostic Potential in Low- and Middle-Income Countries, Focusing on Africa

Nwamekang Belinga L, Espourteille J, Wepnyu Njamnshi Y, Zafack Zeukang A, Rouaud O, Kongnyu Njamnshi A, Allali G, Richetin K.

Neurodegener Dis. 2024;24(1):26-40. doi: 10.1159/000538623. Epub 2024 Mar 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias